The National Asthma Council Information Papers for Health Professionals   Leading the attack against Asthma
NAC Home  Asthma Information Brochures and Papers  
Allergy Lung Function Tests Pain Relievers Air Pollution Complementary Therapies Infant Bedding Diet in Early Childhood Wheezing in the first years of life

Asthma and Pain Relievers

An information paper for health professionals

Introduction
What is ‘aspirin-induced asthma’?
How is aspirin-induced asthma diagnosed?
How is aspirin-induced asthma treated?
Pain relievers and children with asthma
Non-prescription analgesics and asthma
Levels of evidence
References
Content created MAR 2005
Content updated MAR 2005

Get Acrobat Reader here

NextBackHow is aspirin-induced asthma diagnosed?

The diagnosis can be made on history alone, if the patient has a history of asthma or rhinitis triggered within 1-3 hours of taking aspirin or NSAIDs. However, some patients with this condition may never have taken aspirin or NSAIDs. The clinical features of late-onset asthma, and prominent rhinitis with nasal polyposis increase the index of suspicion for AIA.

If the patient is already on regular aspirin or NSAIDs, the diagnosis of AIA is very unlikely, and the medication should not be stopped. Any suspicion of aspirin-induced asthma should be referred to an allergy specialist or respiratory physician for further assessment.

There are no blood tests or skin tests that will diagnose allergy to aspirin or NSAIDs. Confirmation of the diagnosis, if appropriate, requires controlled challenge with aspirin. This should only be done in a specialist clinic with appropriate resuscitation facilities.

How is aspirin-induced asthma treated?

In general, aspirin-induced asthma is managed in the same way as other types of asthma. Some patients with this condition may benefit from the addition of leukotriene receptor antagonist medication such as montelukast, but the response is variable and needs to be judged on an individual basis.

Desensitisation to aspirin is possible by graded introduction of aspirin and staying on a daily maintenance dose. In some patients, desensitisation improves nasal symptoms and asthma control and reduces the recurrence of nasal polyps. Desensitisation is also indicated if the patient requires aspirin or NSAIDs for cardiovascular prophylaxis or the treatment of arthritis. This should only be done under the supervision of a specialist with experience of the procedure.7 <LE III-3>

What pain relievers can patients with aspirin-induced asthma take?

Aspirin and NSAIDs are safe for the majority of people with asthma. Obviously, these medications should be avoided in patients with a positive diagnosis of aspirin-induced asthma, or where there is suspicion of the diagnosis.

Paracetamol is generally safe for patients with diagnosed or suspected aspirin-induced asthma. At high doses (more than 1000-1500mg per dose), paracetamol should be used with caution, as it can inhibit cycloxygenase and cause mild asthma symptoms in some patients sensitive to aspirin.8 <LE III-2>

While the newer COX-2 inhibitors (selective NSAIDs), such as celecoxib, have been used safely in patients with aspirin-induced asthma, occasional cases of anaphylaxis and drug-induced asthma have been reported.9,10 <LE III-1> However, as these medications are new to the market and may not be 100% selective to COX-2, caution is still advised when prescribing them for patients with a history of aspirin-induced asthma, especially at high doses.

Top of Page